Eribulin

Trade Name: 
Halaven
Manufacturer/Distributor: 
Eisai Limited
ca.eisai.com
Classification: 
Antineoplastic agent
ATC Class: 
L01XX41
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2011/12/14
Date Marketed in Canada (yyyy/mm/dd): 
2012/03/10
Presentation: 
Injection: 0.5 mg/mL. DIN: 02377438
Comments: 
For treatment of metastatic breast cancer in patients who have had at least two chemotherapeutic regimens for the treatment of metastatic disease. Prior therapy should have included an anthracycline and a taxine.